- Soy Protein Supplementation Reduces Clinical Indices in Type 2 Diabetes and Metabolic Syndrome
-
Zhang XM, Zhang YB, Chi MH
- KMID: 2374089
- Yonsei Med J.
- 2016 May;57(3):681-689.
- doi: 10.3349/ymj.2016.57.3.681
PURPOSE: Clinical trials have studied the use of soy protein for treating type 2 diabetes (T2D) and metabolic syndrome (MS). The purpose of this study was to outline evidence on... -
- CITED
-
- Close
- SHARE
-
- Close
- Exposure to genistein does not adversely affect the reproductive system in adult male mice adapted to a soy-based commercial diet
-
Lee BJ, Kang JK, Jung EY, Yun YW, Baek IJ, Yon JM, Lee YB, Sohn HS, Lee JY, Kim KS, Nam SY
- KMID: 1099836
- J Vet Sci.
- 2004 Sep;5(3):227-234.
Genistein, a soybean-originated isoflavone, is widely consumed by humans for putative beneficial health effects but its estrogenic activity may affect adversely the development of male reproductive system. Five-week-old ICR mice... -
- CITED
-
- Close
- SHARE
-
- Close
